Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers

Whether human T-lymphotropic virus type 1 (HTLV-1) carriers can develop sufficient humoral immunity after coronavirus disease 2019 (COVID-19) vaccination is unknown.

Source: BMC Infectious Diseases - January 17, 2024 Category: Infectious Diseases Authors: Takuro Kameda, Atae Utsunomiya, Nobuaki Otsuka, Yoko Kubuki, Taisuke Uchida, Kotaro Shide, Ayako Kamiunten, Nobuaki Nakano, Masahito Tokunaga, Takayoshi Miyazono, Yoshikiyo Ito, Kentaro Yonekura, Toshiro Kawakita, Keiichi Akizuki, Yuki Tahira, Masayoshi K Tags: Research Source Type: research